Enzyme Cascade Nanoreactor for Infection Clearance and Regenerative Immune Remodeling in Orthopedic Biofilm Infection
Peilin Zhang, Zhongyi Su, Lingfei Chen, Zilin Chen, Yicheng Wang, Wenhao Lu, Kai Wang, Bin Yu, Teng Gong, Jiaxing Wang, Shen Liu, Xiaonan LiuABSTRACT
Implant‐associated biofilm infection remains a major obstacle to orthopedic repair because persistent bacterial colonization and dysregulated innate immune responses hinder infection resolution and osseointegration. Here, an acid‐responsive enzyme cascade nanoreactor, CaO 2 @CuMOF‐GOx, is engineered to couple biofilm metabolic disruption with regenerative immune remodeling. The nanoreactor comprises an oxygen‐generating CaO 2 component, a Cu‐based metal–organic framework catalytic interface, and immobilized glucose oxidase (GOx). In the acidic and oxygen‐limited biofilm microenvironment, CaO 2 @CuMOF‐GOx supplies O 2 to sustain GOx‐catalyzed glucose consumption and generates H 2 O 2 that undergoes Cu‐mediated Fenton‐like conversion into hydroxyl radical‐mediated oxidative stress. This cascade disrupts bacterial energy metabolism, redox homeostasis, and membrane integrity, thereby suppressing planktonic bacteria and mature biofilms. Importantly, CaO 2 @CuMOF‐GOx also reshapes the inflammatory microenvironment by promoting timely neutrophil apoptosis under metabolic and oxidative stress. These apoptotic neutrophils are efficiently cleared by macrophages, leading to efferocytosis‐associated macrophage reprogramming toward a pro‐reparative phenotype and inflammation resolution. Metabolomic profiling and neutrophil RNA sequencing substantiate bacterial metabolic collapse and activation of intrinsic apoptotic programs in neutrophils. In a rat implant‐associated infection model, local CaO 2 @CuMOF‐GOx treatment reduces bacterial burden, alleviates peri‐implant inflammation, and enhances bone regeneration and osseointegration. This study presents a biofilm‐responsive immunometabolic nanotherapy that integrates infection eradication with regenerative immune remodeling for orthopedic implant‐associated infections.